These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34288954)

  • 1. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center.
    Friedman EE; Devlin SA; McNulty MC; Ridgway JP
    PLoS One; 2021; 16(7):e0254994. PubMed ID: 34288954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
    Overton ET; Weir IR; Zanni MV; Fischinger S; MacArthur RD; Aberg JA; Fitch KV; Frank M; Albrecht H; Goodenough E; Rhame FS; Fichtenbaum CJ; Bloomfield GS; Malvestutto C; Supparatpinyo K; McCallum S; Douglas PS; Alter G; Ribaudo H; Grinspoon SK
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):377-381. PubMed ID: 35413022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Testing Among People with HIV: A Population Level Analysis Based on Statewide Data in South Carolina.
    Shi F; Zhang J; Yang X; Gao H; Chen S; Weissman S; Olatosi B; Li X
    AIDS Behav; 2024 Oct; 28(Suppl 1):22-32. PubMed ID: 38109020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort.
    Berenguer J; Díez C; Martín-Vicente M; Micán R; Pérez-Elías MJ; García-Fraile LJ; Vidal F; Suárez-García I; Podzamczer D; Del Romero J; Pulido F; Iribarren JA; Gutiérrez F; Poveda E; Galera C; Izquierdo R; Asensi V; Portilla J; López JC; Arribas JR; Moreno S; González-García J; Resino S; Jarrín I
    Clin Microbiol Infect; 2021 Nov; 27(11):1678-1684. PubMed ID: 34186209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between comorbidities and coronavirus disease 2019 hospitalization among people with HIV differs by age.
    Moran CA; Oliver NT; Szabo B; Collins LF; Nguyen MLT; Shah NS; Moanna A; Colasanti JA; Cantos VD; Armstrong WS; Sheth AN; Ofotokun I; Kelley CF; Marconi VC; Lahiri CD
    AIDS; 2023 Jan; 37(1):71-81. PubMed ID: 36111530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
    D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
    Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
    JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study.
    Hanna JJ; Geresu LB; Diaz MI; Ho M; Casazza JA; Pickering MA; Lanier HD; Radunsky AP; Cooper LN; Saleh SN; Bedimo RJ; Most ZM; Perl TM; Lehmann CU; Turer RW; Chow JY; Medford RJ
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad400. PubMed ID: 37577110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts.
    Park LS; McGinnis KA; Gordon KS; Justice AC; Leyden W; Silverberg MJ; Skarbinski J; Jefferson C; Horberg M; Certa J; Napravnik S; Edwards JK; Westreich D; Bastarache L; Gangireddy S; Benning L; D'Souza G; Williams C; Althoff KN;
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):249-255. PubMed ID: 35195574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Load Suppression in People Living with HIV Before and During the COVID-19 Pandemic in Brooklyn, New York.
    Cocorpus J; Holman S; Yager JE; Helzner E; Sardar M; Kohlhoff S; Smith-Norowitz TA
    AIDS Behav; 2024 Sep; 28(9):2961-2969. PubMed ID: 38836987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. People with HIV have a higher risk of COVID-19 diagnosis but similar outcomes to the general population.
    Tang ME; Gaufin T; Anson R; Zhu W; Mathews WC; Cachay ER
    HIV Med; 2022 Nov; 23(10):1069-1077. PubMed ID: 35394110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID With Exercise Capacity and Chronotropic Incompetence Among People With HIV.
    Durstenfeld MS; Peluso MJ; Spinelli MA; Li D; Hoh R; Chenna A; Yee B; Winslow J; Petropoulos C; Gandhi M; Henrich TJ; Aras MA; Long CS; Deeks SG; Hsue PY
    J Am Heart Assoc; 2023 Oct; 12(20):e030896. PubMed ID: 37830367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals.
    Johnston R
    Curr Opin HIV AIDS; 2021 Jan; 16(1):54-62. PubMed ID: 33165007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
    Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.
    Del Amo J; Polo R; Moreno S; Jarrín I; Hernán MA
    AIDS; 2022 Feb; 36(2):161-168. PubMed ID: 34934017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Severity in People With HIV Compared With Those Without HIV.
    Nguyen VT; Nagavedu K; Morrison M; Chen T; Randall LM; Landazabal C; John B; Klompas M; Cocoros NM
    J Acquir Immune Defic Syndr; 2024 Apr; 95(5):479-485. PubMed ID: 38301641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study.
    Yendewa GA; Perez JA; Patil N; McComsey GA
    Front Immunol; 2024; 15():1297195. PubMed ID: 38318191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
    de Lusignan S; Dorward J; Correa A; Jones N; Akinyemi O; Amirthalingam G; Andrews N; Byford R; Dabrera G; Elliot A; Ellis J; Ferreira F; Lopez Bernal J; Okusi C; Ramsay M; Sherlock J; Smith G; Williams J; Howsam G; Zambon M; Joy M; Hobbs FDR
    Lancet Infect Dis; 2020 Sep; 20(9):1034-1042. PubMed ID: 32422204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa.
    Kassanjee R; Davies MA; Ngwenya O; Osei-Yeboah R; Jacobs T; Morden E; Timmerman V; Britz S; Mendelson M; Taljaard J; Riou J; Boulle A; Tiffin N; Zinyakatira N
    J Int AIDS Soc; 2023 Jun; 26(6):e26104. PubMed ID: 37339333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.